These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3533561)

  • 1. Comparison of the antihypertensive effect of urapidil and metoprolol in hypertension.
    Leonetti G; Mazzola C; Boni S; Guffanti E; Meani A; Zanchetti A
    Eur J Clin Pharmacol; 1986; 30(6):637-40. PubMed ID: 3533561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive effects of urapidil and clonidine: a double-blind cross-over study.
    Kanniainen E; Heikkilä O; Jääskeläinen T; Lilja M; Jounela AJ
    Eur J Clin Pharmacol; 1985; 28(1):35-9. PubMed ID: 3886400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diltiazem in the treatment of mild or moderate essential hypertension. Comparison with metoprolol in a crossover double-blind trial.
    Trimarco B; DeLuca N; Ricciardelli B; Volpe M; Veniero A; Cuocolo A; Cicala M
    J Clin Pharmacol; 1984; 24(5-6):218-27. PubMed ID: 6378988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A
    Blood Press Suppl; 1995; 3():38-46. PubMed ID: 8535541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of urapidil and atenolol in hypertension.
    Török E; Wagner M; Podmaniczky M
    Drugs; 1988; 35 Suppl 6():164-72. PubMed ID: 3042356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of felodipine on rest and exercise heart rate and blood pressure in hypertensive patients.
    Lorimer AR; McAlpine HM; Rae AP; Simpson IA; Barbour MP; Forret EA; Hill TW; Lawrie TD
    Drugs; 1985; 29 Suppl 2():154-7. PubMed ID: 3886358
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the duration of antihypertensive action of atenolol and metoprolol over a 24-hour period.
    Crowe PF; Ferguson RJ
    Curr Med Res Opin; 1985; 9(7):431-5. PubMed ID: 4028805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Protection of the hypertensive patient: comparative study of atenolol and metoprolol].
    Mazzari M; Coppola E; Montenero AS; Schiavoni G; Domenichelli B; Mongiardo R; Pennestrì F
    Cardiologia; 1982; 27(8):753-63. PubMed ID: 6765444
    [No Abstract]   [Full Text] [Related]  

  • 10. Mode of action of beta-adrenoceptor blocking agents in hypertension. A comparison between metoprolol and pindolol with special reference to peripheral vascular effects.
    Svensson A; Gudbrandsson T; Sivertsson R; Hansson L
    Acta Med Scand Suppl; 1982; 665():103-8. PubMed ID: 6760678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive effects at rest and during exercise of a calcium blocker, nifedipine, alone and in combination with metoprolol.
    Ekelund LG; Ekelund C; Rössner S
    Acta Med Scand; 1982; 212(1-2):71-5. PubMed ID: 6751026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of propranolol and metoprolol on haemodynamic and respiratory indices and on perceived exertion during exercise in hypertensive patients.
    van Herwaarden CL; Binkhorst RA; Fennis JF; van't Laar A
    Br Heart J; 1979 Jan; 41(1):99-105. PubMed ID: 371643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of clinical trials with urapidil.
    Schook CE; Radtke H; Wurst W; Thieme G
    Am J Cardiol; 1989 Aug; 64(7):30D-37D. PubMed ID: 2667312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenoceptor stimulating and blocking agents in essential hypertension: single and combined therapy with terbutaline and metoprolol.
    Schulte KL; Meyer-Sabellek W; Thiede HM; Röcker L; Gotzen R
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):539-44. PubMed ID: 3323072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antihypertensive effect and tolerance to urapidil. Comparison with nifedipine in a multicenter double-blind study].
    Stumpe KO; Feldhaus P; Haerlin R
    Fortschr Med; 1989 Jan; 107(1):54-7. PubMed ID: 2646188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute responses to urapidil in hypertensive persons.
    de Leeuw PW; Birkenhäger WH
    Am J Cardiol; 1989 Aug; 64(7):22D-24D. PubMed ID: 2667310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Exercise performance after long-term administration of enalapril or metoprolol. A randomized double-blind study of hypertensive leisure-time sportsmen].
    Teixeira A; Billigmann PW; Bohner H; Schumacher H
    Dtsch Med Wochenschr; 1992 Jun; 117(25):967-73. PubMed ID: 1611965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive effect of a non-selective (propranolol) and a cardioselective (metoprolol) beta-adrenoceptor blocking agent at rest and during exercise.
    Clausen N; Damsgaard T; Mellemgaard K
    Br J Clin Pharmacol; 1979 Apr; 7(4):379-83. PubMed ID: 375959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study with the competitive 5-HT2-serotonergic antagonist ketanserin.
    Ferrara LA; Fasano ML; Rubba P; Soro S; Marotta G; Mancini M
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S159-60. PubMed ID: 2412041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urapidil. A reappraisal of its use in the management of hypertension.
    Dooley M; Goa KL
    Drugs; 1998 Nov; 56(5):929-55. PubMed ID: 9829161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.